Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Documentary spotlighting CAPS students set for sold-out premiere (Watch the trailer)
There’s no syllabus for life, laments a teenage student in a soon-to-be released documentary detailing the impact of experiential learning on the new generation of youth about to enter the workforce. The documentary — “Where Students Lead” — heavily showcases student voice and the Center for Advanced Professional Studies, said Corey Mohn, executive director of…
Serial builder uses sensor tech to ‘see’ inside problem-prone properties with Particle Space
Passion for building breathes life into a successful startup and the collective ecosystem, said David Biga. “[Builders] are a critical piece to our startup community,” said Biga, founder of Kansas City-based SaaS firm Particle Space. “If you don’t have people who care to build and offer things to those before you — then why come…
Duo designs Paloma Post greeting cards for more inclusive representation of couples
As she stood flipping through an endless sea of birthday cards, Julie Korona couldn’t find a single one that would send the right message to her then-fiancé, Tyler, she recalled. “All of the cards that I was looking through either said ‘husband’ or were super generic,” said Korona, co-founder of Paloma Post — a newly…
Artist who won rare Jayhawk licensing deal — scoring a $150K payday — set to rebound
Seemingly routine for many Kansas fans, crimson and blue are once again among the colors flooding the canvas of the 2019 NCAA tournament. But for artist Megh Knappenberger, the Jayhawks’ familiar palate has painted an entrepreneurial journey with as thrilling ups and downs as Big 12 basketball, she said. “It’s a pretty special and unique…